Sartorius’ single-use bioreactor and automation platform introduce innovations that will change the field of biopharmaceutical process development and manufacturing
The agreement is aimed at facilitating the development and validation of a methodology for the quantification of micro- and nano-plastics up to 0.3 µm in size by Eurofins | IPROMA using a Markes International instrument
Markes has now further developed the platform by adding the ability to give laboratories finer automation control levels and enhanced sampling capabilities